Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
86.06 USD | +1.22% | -1.40% | +20.50% |
May. 13 | Ligand Pharmaceuticals Insider Sold Shares Worth $830,449, According to a Recent SEC Filing | MT |
May. 08 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
Business Summary
Number of employees: 58
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Biopharmaceutical
100.0
%
| 196 | 100.0 % | 131 | 100.0 % | -33.09% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 196 | 100.0 % | 131 | 100.0 % | -33.09% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Todd Davis
CEO | Chief Executive Officer | 63 | 07-02-28 |
Octavio Espinoza
DFI | Director of Finance/CFO | 53 | 22-10-31 |
President | 49 | 15-08-05 | |
Andrew Reardon
LAW | General Counsel | 49 | 21-12-31 |
Corporate Officer/Principal | - | Feb. 19 | |
Karen Reeves
PRN | Corporate Officer/Principal | - | Feb. 19 |
Human Resources Officer | - | 94-11-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
John Kozarich
CHM | Chairman | 74 | 03-02-28 |
John LaMattina
BRD | Director/Board Member | 74 | 11-01-31 |
Stephen Sabba
BRD | Director/Board Member | 64 | 08-08-03 |
Jason Aryeh
BRD | Director/Board Member | 56 | 06-09-26 |
Todd Davis
CEO | Chief Executive Officer | 63 | 07-02-28 |
Nancy Gray
BRD | Director/Board Member | 64 | 17-08-17 |
Director/Board Member | 55 | 23-09-25 | |
Jason Haas
BRD | Director/Board Member | 56 | 22-06-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 17,963,653 | 17,542,452 ( 97.66 %) | 0 | 97.66 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
3,616,077 | 3.31% | 249,003,062 $ |
Company contact information
Ligand Pharmaceuticals, Inc.
555 Heritage Drive Suite 200
33458, Jupiter
+858 550 7500
http://www.ligand.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.50% | 1.55B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- LGND Stock
- Company Ligand Pharmaceuticals Incorporated